- 🌉 San Francisco “Decriminalizes” Psychedelics
- 📖 Assorted Reading
This week’s Bulletin is shorter than usual…
Psychedelic Sector News & Assorted Reading
San Francisco “Decriminalizes” Psychedelics
“Decriminalization” is a term that describes a variety of initiatives, and as such frequently entices pedants out of the woodwork. However, there is some reason to be concerned around sloppy reporting on psychedelic drug policy reforms.
This headline from NowThis News (part of the Vox Media group) is particularly misleading: ‘Shrooms are now officially legal in San Francisco’. Decriminalization does not equate to legalisation, with the former generally meaning that those using psychedelics will not be investigated, arrested or prosecuted and the latter referring to the establishment of a legal framework for psychedelics, which would almost certainly happen at the state level (as in Oregon).
Now, imagine that someone reads this headline on NowThis, which is geared toward bite-sized social media glances, and then runs afoul of the law by openly selling psychedelics, for example. The distinction is not exclusively the remit of armchair linguists, then.
“Deprioritization” is, arguably, a better term to use when referring to local reforms that seek to make the investigation, arrest and prosecution of personal possession and use of psychedelics (and other substances, of course) the lowest law enforcement priority. The ‘weakest’ manifestation of such initiatives sees lawmakers ‘urge’ law enforcement officers to deprioritize enforcement (as in SF), while ‘stronger’ deprioritization resolutions might scrap funding for such enforcement efforts.
Anyhow, the resolution (which was passed unanimously) urges the Mayor of the City and County of San Francisco to instruct state and federal lobbyists to support the decriminalization of all “Entheogenic Plants and plant-based compounds that are listed on the Federal Controlled Substances Schedule 1”. It is further resolved that the Board of Supervisors urges local law enforcement agencies to make the investigation and arrest of individuals engaged in the adult use, cultivation, purchasing, transporting, and distributing of such substances among the lowest priority for the City.
The also urges state and federal officials to “work in collaboration” to support decriminalization at a broader level.
- Matt Zorn’s latest over at On Drugs takes aim at The Sewell Patent, which is one of the primary subjects of the Scott Freeman lawsuit we covered last week.
- Legendary shoe designer Patrick Cox discusses his experiences with 5-MeO-DMT in an interview with the Guardian’s Hadley Freeman.
- Psychedelic Show is an exhibition coming to Toronto from September 30.
- Insider’s Catherine Schuster-Bruce reports on a couple that spent $6k of their life savings on psychedelic therapy to repair their 10-year marriage.
- SCMP speaks to Beckley Retreats about their Jamaica and Netherlands offerings.
- “An Rx For Mushrooms?” asks Zocdoc’s The Paper Gown publication, which looks at “The Future of Psychedelic Therapy”.
- Johns Hopkins Hub shares a piece on “Preparing for a new era of psychedelic treatment”, which discusses a mult-university project to develop fellowships and training programs in psychedelic therapy 9with Yale and NYU, funded by Heffter Research Institute).
- Video: World Science Festival hosts Rick Doblin, Gül Dölen, and comedian Reggie Watts in a one-and-a-half hour long discussion titled, “Psychedelics: Chemicals, Consciousness, and Creativity”.
- A look at what researchers at University of Toronto are up to when it comes to psychiatry and psychedelics.
- The UK’s Evening Standard profiles King’s College London’s psilocybin for anorexia trial, sponsored by Compass Pathways.
- Rachel Eddie reports on efforts to ban psychedelic medicine in the state of Victoria in Australia, where psychiatrists can apply for an exemption to use MDMA and psilocybin for clients.
New Podcast: Minority Trip Report
Raad Seraj’s new podcast is finally here…
Minority Trip Report (MTR) is a podcast for under represented views and life journeys with mental health, psychedelics, and consciousness.
Available via Apple Podcasts and Spotify. More info on their website.
Featured Psychedelic Jobs
Johns Hopkins’ Behavioral Pharmacology Research Unit is hiring a Research Program Supervisor.
COMPASS Pathways is hiring a number of roles.
Browse more roles and get more job posts to your inbox by signing up for alerts here.
Join our newsletter to have our Weekly Bulletin delivered to your inbox every Friday evening. We summarise the week’s most important developments and share our Weekend Reading suggestions.